Clinical Trials
Participating in research is one of the most powerful things you can do to be part of tomorrow's healthcare breakthroughs. Penn State Health is always looking for people who are willing to participate in studies, so that our researchers can better understand how to diagnose, treat, and prevent diseases and conditions.
Pfizer, in collaboration with the European company Valneva, is developing a vaccine called VLA15 to protect people against an infectious disease called Lyme borreliosis, also known as Lyme disease (LD).
...
A research study on an experimental vaccine for Lyme disease. The study doctor wants to learn how safe the vaccine is for children between 5 and 17 years old. This
...
A research study on an experimental vaccine for Lyme disease. The study doctor wants to learn how safe the vaccine is for children between 5 and 17 years old. This
...
This trial will address the safety of withdrawing hydroxychloroquine (HCQ) in patients with systemic lupus erythematous who are 60 years of age or older. In this older population the need
...
BMN 331 is an experimental drug that is being tested for the treatment of patients with HAE. This study is the first time BMN 331, which is a gene therapy
...
BMN 331 is an experimental drug that is being tested for the treatment of patients with HAE. This study is the first time BMN 331, which is a gene therapy
...
The main purpose of the study is to evaluate the safety and tolerability of an injection of the study drug in participants with Hereditary Angioedema. This study is open-label, which
...
The main purpose of the study is to evaluate the safety and tolerability of an injection of the study drug in participants with Hereditary Angioedema. This study is open-label, which
...
This study is for patients with SLE (systemic lupus erythematosus) to determine the effectiveness and safety of drug CC-220 on improving SLE and to see how well the body tolerates
...
This study involves the use of a new medicine known as ISIS 721744 as a new treatment for Hereditary Angioedema, which is designed to lower the amount of a protein
...